STL Volume 10 Number 1

4 POSTS 0 COMMENTS
Update on Drugs and Drug News

Update on Drugs and Drug News February 2005

Updates on: Alefacept AMEVIVE® Dapsone Gel 5% Aczone® Nitroglycerin Ointment Cellegesic® Cefdinir Oral Suspension Omnicef® Ultrasonic Skin Permeation Device SonoPrep® Tazarotene Capsules
image of silk fabric and dry skin

Clinical Use of RESTYLANE®

There is no ideal filler, nor will there be a single product that can satisfy all requirements. However, RESTYLANE®, a non-animal, stabilized hyaluronic acid (NASHA, Medicis), is a very versatile augmenting agent. It has been in clinical use for 8 years and experience has shown it to be close to the ideal filler in many respects.
Valacyclovir for the Management of Herpes Viral Infections

Valacyclovir for the Management of Herpes Viral Infections

The Herpesviridae family (Types 1-8) continues to inflict considerable morbidity and social stigma upon humanity. Once infected with the herpes viruses, especially Types 1-3, they establish permanent residence within our nervous system and reactivate during periods of stress, trauma, and/or other precipitating factors.

POPULAR